1053655-66-5

Basic information

• Product Name: 7-Bromo[1,2,4]triazolo[1,5-a]pyridine
• Synonyms: 7-Bromo[1,2,4]triazolo[1,5-a]pyridine;7-Bromo[1,2,4]triazolo[1,...;7-broMo-[1;[1,2,4]Triazolo[1,5-a]pyridine, 7-bromo-
• CAS NO: 1053655-66-5
• Molecular Formula: C₆H₄BrN₃
• Molecular Weight: 198.02006
• Product Categories: Heterocycle-Pyridine series
• Mol File: 1053655-66-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.89±0.1 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 1.76±0.30(Predicted)
• CAS DataBase Reference: 7-Bromo[1,2,4]triazolo[1,5-a]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Bromo[1,2,4]triazolo[1,5-a]pyridine(1053655-66-5)
• EPA Substance Registry System: 7-Bromo[1,2,4]triazolo[1,5-a]pyridine(1053655-66-5)

Safety Data

• Hazardous Substances Data: 1053655-66-5(Hazardous Substances Data)

Usage

General Description

7-Bromo[1,2,4]triazolo[1,5-a]pyridine, also known as BTP, is a chemical compound with the molecular formula C5H3BrN4. It is a nitrogen-containing heterocyclic compound and has a pyridine ring fused with a triazole ring. BTP is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It has been found to exhibit potential biological activities, including antiviral and antibacterial properties. BTP is also used as an intermediate in the production of various other chemical compounds. Due to its versatile nature and potential therapeutic applications, BTP is a widely studied and utilized compound in the field of medicinal chemistry.

Upstream product

• 84249-14-9 2-amino-4-bromopyridine 
• 64-18-6 formic acid 
• 1202704-61-7 1,2-diamino-4-bromopyridin-1-ium-2,4,6-trimethylbenzenesulfonate 

Downstream Products

• 1210048-18-2 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridine 
• 1202701-61-8 (R)-3-(3-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yl)phenyl)-5-([1,2,3]triazol-1-yl)methyloxazolidin-2-one 
• 1202701-54-9 (S)-(N-3-(3-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yl)phenyl)-2-oxo-5-oxazolidinyl)methylacetamide 
• 1201643-69-7 [1,2,4]triazolo[1,5-a]pyridin-6-ylboronic acid 

Relevant articles and documents

FUSED RING HETEROARYL COMPOUNDS AS ALK4/5 INHIBITORS

The invention provides novel substituted heterocyclic compounds represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of ALK5 and/or ALK4 and are useful in the treatment of pulmonary fibrosis, NASH, obesity, diabetes, cancers and other inflammation.

SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF

The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.